Knud Schewe

1.9k citations

47 papers · 1.2k indexed · h-index 19

Impact in

Virology top 2%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- COVID-19 Clinical Research Studies

Papers in ⓘ

Virology 15
- HIV Research and Treatment 15
Hepatology 20
- Hepatitis C virus research 20

Co-authors: Christoph Boesecke (17 shared papers)Thomas A. Lutz (18 shared papers)Axel Baumgarten (16 shared papers)Patrick Ingiliz (18 shared papers)Bonaventura Clotet (2 shared papers)Christian Hoffmann (7 shared papers)Norbert Bischofberger (1 shared paper)Mark Nelson (1 shared paper)
Journals: Journal of Hepatology (6 papers)Infection (6 papers)HIV Medicine (3 papers)Journal of the International AIDS Society (3 papers)Antiviral Therapy (3 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Knud Schewe

47 papers receiving 1.2k citations

Peers

Countries citing papers authored by Knud Schewe

Since Specialization

Citations

This map shows the geographic impact of Knud Schewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knud Schewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knud Schewe more than expected).

Fields of papers citing papers by Knud Schewe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Knud Schewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knud Schewe. The network helps show where Knud Schewe may publish in the future.

Co-authors

The 25 scholars most cited alongside Knud Schewe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Knud Schewe Line = papers co-authored together Knud Schewe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years AIDS ·Mark Nelson, Christine Katlama, Joan Montaner, David A. Cooper, Brian Gazzard, Bonaventura Clotet, Adriano Lazzarin, Knud Schewe, Joep M. A. Lange, Christina Wyatt, Sue Curtis, Shan-Shan Chen, Stephen A. Smith, Norbert Bischofberger, James F. Rooney	2007	268
2	COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients Infection ·Georg Härter, Christoph D. Spinner, Julia Roider, Markus Bickel, Ivanka Krznaric, Stephan Grunwald, Farhad Schabaz, Daniel Gillor, Nils Postel, Matthias Mueller, Markus Müller, Katja Römer, Knud Schewe, Christian Hoffmann	2020	152
3	Detection of minor populations of drug-resistant HIV-1 in acute seroconverters AIDS ·Karin J. Metzner, Pia Rauch, Hauke Walter, Christoph Boesecke, Bernhard Zöllner, Heiko Jessen, Knud Schewe, Stefan Fenske, Holger Gellermann, Hans‐Jürgen Stellbrink	2005	86
4	Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada AIDS Care ·Kevin Robertson, Carmen Bayón, Jean‐Michel Molina, Patricia McNamara, Christiane Resch, José A. Muñoz-Moreno, Ranjababu Kulasegaram, Knud Schewe, Angel Burgos-Ramirez, Cristina de Álvaro, Esther Cabrero, Matthew Guion, Michael Norton, Jean van Wyk	2014	82
5	Pegylated Interferon-α for the Treatment of Sexually Transmitted Acute Hepatitis C in HIV-Infected Individuals Antiviral Therapy ·Martin Vogel, Jacob Nattermann, Axel Baumgarten, Gerd Klausen, B Bieniek, Knud Schewe, Heiko Jessen, Christoph Boesecke, Michael Rausch, Thomas A. Lutz, Stefan Fenske, Dietmar Schranz, Tim Kümmerle, Christoph Schuler, Albert Theisen, Christoph Mayr, Thomas Seidel, Jürgen K. Rockstroh	2006	52
6	Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era Clinical Infectious Diseases ·Patrick Ingiliz, Malte H. Wehmeyer, Christoph Boesecke, Julian Schulze zur Wiesch, Knud Schewe, Thomas A. Lutz, Axel Baumgarten, Karl‐Georg Simon, D. Hueppe, Juergen Rockstroh, Stefan Mauss, Stefan Christensen, (unknown), (unknown)	2019	49
7	Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01) Clinical Infectious Diseases ·Patrick Ingiliz, Stefan Christensen, Torben Kimhofer, D. Hueppe, Thomas A. Lutz, Knud Schewe, Heiner Busch, G Schmutz, Malte H. Wehmeyer, Christoph Boesecke, Karl‐Georg Simon, F. Berger, Jürgen K. Rockstroh, Julian Schulze zur Wiesch, Axel Baumgarten, Stefan Mauss	2016	44
8	Effect of Antiviral Therapy for HCV on Lipid Levels Antiviral Therapy ·Stefan Mauss, F. Berger, Malte H. Wehmeyer, Patrick Ingiliz, D. Hueppe, Thomas A. Lutz, Karl Georg Simon, Knud Schewe, Juergen Rockstroh, Axel Baumgarten, Stefan Christensen	2016	41
9	High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM Infection ·Christian Hoffmann, Hany Sahly, Andrea Jessen, Patrick Ingiliz, HJ Stellbrink, Stefan Neifer, Knud Schewe, Susann Dupke, A. Baumgarten, A. Kuschel, Ivanka Krznaric	2013	39
10	Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients Hepatology ·Jacob Nattermann, Martin Vogel, Thomas Berg, Mark Danta, Baumgarten Axel, Christoph Mayr, Raffaele Bruno, C. Tural, Gerd Klausen, Bonaventura Clotet, Thomas A. Lutz, F Grünhage, Michael Rausch, Hans Dieter Nischalke, Knud Schewe, Bernhard Bienek, Georg Haerter, Tilman Sauerbruch, Juergen Rockstroh, Ulrich Spengler	2007	35
11	High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance‐associated substitutions in hepatitis C genotype 3 infection Alimentary Pharmacology & Therapeutics ·Johann von Felden, Johannes Vermehren, Patrick Ingiliz, Stefan Mauss, Thomas A. Lutz, Karl‐Georg Simon, H. Busch, Axel Baumgarten, Knud Schewe, D. Hueppe, Christoph Boesecke, JK Rockstroh, Martin Daeumer, Nadine Luebke, Jörg Timm, Julian Schulze zur Wiesch, Christoph Sarrazin, Stefan Christensen	2018	35
12	Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058 Eurosurveillance ·David van de Vijver, Ann-Kathrin Richter, Charles A. Boucher, Barbara Gunsenheimer‐Bartmeyer, Christian Kollan, Brooke E Nichols, Christoph D. Spinner, Jürgen Wasem, Knud Schewe, Anja Neumann	2019	28
13	Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 Weeks HIV Clinical Trials ·Federico Pulido, Vicente Estrada, J.G. Baril, Ken Logue, Knud Schewe, Andreas Plettenberg, Dan Duiculescu, Linda H. Y. Yau, Cindy Vavro, Michael L. Lim, Cristina E. Pharo	2009	25
14	Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study The European Journal of Health Economics ·Sarah Mostardt, Nikola Hanhoff, Jürgen Wasem, Armin Goetzenich, Knud Schewe, Eva Wolf, Christoph Mayr, Hans Jaeger, Holger Pfaff, S Dupke, Anja Neumann	2012	22
15	Short-Term Neuropsychiatric Tolerability of Bictegravir Combined with Emtricitabine/Tenofovir Alafenamide in Clinical Practice Antiviral Therapy ·Christian Hoffmann, Knud Schewe, Stefan Fenske, Thomas Buhk, Michael Sabranski, Axel Adam, Stefan Hansen, Hans‐Jürgen Stellbrink	2019	22
16	Eliminating Hepatitis C Virus Among Human Immunodeficiency Virus–Infected Men Who Have Sex With Men in Berlin: A Modeling Analysis The Journal of Infectious Diseases ·Natasha K. Martin, Klaus Jansen, Matthias an der Heiden, Christoph Boesecke, Anders Boyd, Knud Schewe, Axel Baumgarten, Thomas A. Lutz, Stefan Christensen, Alexander Thielen, Stefan Mauss, Jürgen K. Rockstroh, Britt Skaathun, Patrick Ingiliz	2019	21
17	2016 PREP attitudes in Germany: high awareness and acceptance in MSM at risk of HIV Infection ·Christoph D. Spinner, Nikola Hanhoff, Ivanka Krznaric, Gaby Knecht, Tim Kuemmerle, Robin Ruesenberg, Knud Schewe	2018	19
18	Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort European journal of medical research ·(unknown), C Koegl, Eva Wolf, Nikola Hanhoff, Heiko Jessen, Knud Schewe, Michael Rausch, J. Goelz, Andreas Goetzenich, Heribert Knechten, H. Jaeger	2009	18
19	Anxiety, depression, and health-related quality of life in aging people living with HIV compared to diabetes patients and patients with minor health conditions: a longitudinal study Psychology Health & Medicine ·Joram Ronel, Andreas Dinkel, Eva Wolf, Birgitt Marten‐Mittag, Birgit Mueck, Christoph Mayr, Christian Hoffmann, Martin F Karwat, Knud Schewe, Axel Baumgarten, Hans Jaeger	2018	18
20	Everything fine so far? Physical and mental health in HIV‐infected patients with virological success and long‐term exposure to antiretroviral therapy Journal of the International AIDS Society ·Gesa Erdbeer, Michael Sabranski, Ina Sonntag, Albrecht Stoehr, Heinz‐A. Horst, Andreas Plettenberg, Knud Schewe, Stefan Unger, Hans‐J. Stellbrink, Stefan Fenske, Christian Hoffmann	2014	17

About Knud Schewe

Knud Schewe is a scholar working on Virology, Hepatology, Infectious Diseases, Emergency Medicine and Epidemiology, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (22 papers), Hepatitis C virus research (20 papers), HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (13 papers), Hepatitis B Virus Studies (10 papers), HIV-related health complications and treatments (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and HIV, Drug Use, Sexual Risk (6 papers). The work is most often cited by research in Virology (300 citations), Infectious Diseases (867 citations), Hepatology (350 citations), Emergency Medicine (219 citations) and Epidemiology (546 citations). Knud Schewe has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Christoph Boesecke, Thomas A. Lutz, Axel Baumgarten, Patrick Ingiliz, Bonaventura Clotet, Christian Hoffmann, Norbert Bischofberger, Mark Nelson, James F. Rooney and Joep M. A. Lange. Their work appears in journals such as Journal of Hepatology, Infection, HIV Medicine, Journal of the International AIDS Society and Antiviral Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact